Potential Therapies Targeting the Metabolic Reprogramming of Diabetes-Associated Breast Cancer
In recent years, diabetes-associated breast cancer has become a significant clinical challenge. Diabetes is not only a risk factor for breast cancer but also worsens its prognosis. Patients with diabetes usually show hyperglycemia and hyperinsulinemia, which are accompanied by different glucose, pro...
Main Authors: | Hang Chee Erin Shum, Ke Wu, Jaydutt Vadgama, Yong Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-01-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/13/1/157 |
Similar Items
-
A Novel Metabolic Reprogramming Strategy for the Treatment of Diabetes‐Associated Breast Cancer
by: Qiongyu Hao, et al.
Published: (2022-02-01) -
Editorial: Metabolic reprogramming in breast cancer
by: Cristian Scatena, et al.
Published: (2022-11-01) -
Energy metabolism pathways in breast cancer progression: The reprogramming, crosstalk, and potential therapeutic targets
by: Xuewei Zheng, et al.
Published: (2022-12-01) -
Glucose Metabolic Reprogramming of ER Breast Cancer in Acquired Resistance to the CDK4/6 Inhibitor Palbociclib<sup>+</sup>
by: Nicla Lorito, et al.
Published: (2020-03-01) -
Metabolic reprogramming in cancer: Mechanisms and therapeutics
by: Shiqi Nong, et al.
Published: (2023-04-01)